Orchid Pharma Ltd
NSE:ORCHPHARMA
Orchid Pharma Ltd
NSE:ORCHPHARMA
Price:
531.65
INR
3.95%
Market Closed
Market Cap:
₹27B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Orchid Pharma Ltd
NSE:ORCHPHARMA
|
IN |
|
Decibel Cannabis Company Inc
XTSX:DB
|
CA |
|
Nexi SpA
MIL:NEXI
|
IT |
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
CN |
|
US Energy Corp
NASDAQ:USEG
|
US |
|
C
|
City Development Environment Co Ltd
SZSE:000885
|
CN |
|
Natura & Co Holding SA
BOVESPA:NTCO3
|
BR |
|
J
|
Jiangsu Allfavor Intelligent Circuits Technology Co Ltd
SZSE:300964
|
CN |
|
S
|
Sierra Rutile Holdings Ltd
ASX:SRX
|
AU |
|
Eaglerise Electric & Electronic China Co Ltd
SZSE:002922
|
CN |
|
S
|
Sare Holding SAB de CV
BMV:SAREB
|
MX |
|
Pixel Companyz Inc
TSE:2743
|
JP |
|
Saudi British Bank SJSC
SAU:1060
|
SA |
|
S
|
Srithai Superware PCL
SET:SITHAI
|
TH |
|
Cogobuy Group
HKEX:400
|
CN |
|
Techmatrix Corp
TSE:3762
|
JP |
|
C
|
Coral Laboratories Ltd
BSE:524506
|
IN |
|
GMO Financial Holdings Inc
TSE:7177
|
JP |
|
B
|
Bin Ulasim ve Akilli Sehir Teknolojileri AS
IST:BINBN.E
|
TR |
|
D
|
Dongfang Electric Corp Ltd
SSE:600875
|
CN |
|
Datadog Inc
NASDAQ:DDOG
|
US |
|
NACL Industries Ltd
NSE:NACLIND
|
IN |
Relative Value
The Relative Value of one
ORCHPHARMA
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 531.65 INR,
Orchid Pharma Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ORCHPHARMA Relative Value
HIDDEN
Multiples Across Competitors
ORCHPHARMA Competitors Multiples
Orchid Pharma Ltd Competitors
Orchid Pharma Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Orchid Pharma Ltd
NSE:ORCHPHARMA
|
25.9B INR | 3.3 | 142.9 | 66.5 | 409.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 13.3 | 41.9 | 28.3 | 30.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.4B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD | 4.5 | 16.2 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.2B GBP | 5 | 28.6 | 15.9 | 22.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.4B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.6B USD | 2.5 | 16.8 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
